Live Breaking News & Updates on Oncologic Sciences
Stay updated with breaking news from Oncologic sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The combination of dabrafenib and trametinib plus navitoclax generated responses and met the co-primary end point for complete response rate vs historical controls in patients with BRAF V600–mutant metastatic melanoma. ....
/PRNewswire/ Debbie s Dream Foundation: Curing Stomach Cancer (DDF) is excited to announce its upcoming Free Stomach Cancer Educational Symposium in. ....
Patients with unresectable metastatic desmoplastic melanoma achieved high response rates when treated with single-agent pembrolizumab in the SWOG S1512 trial, according to data presented during the 2023 AACR Annual Meeting. ....